GSK Sues Mylan, Impax Over Generic Prostate Drugs
GlaxoSmithKline PLC filed a lawsuit Friday accusing Mylan Inc. and Impax Laboratories Inc. of infringing three patents that cover its enlarged prostate treatments, Avodart and Jalyn....To view the full article, register now.
Already a subscriber? Click here to view full article